Rapt Therapeutics Inc
NASDAQ:RAPT

Watchlist Manager
Rapt Therapeutics Inc Logo
Rapt Therapeutics Inc
NASDAQ:RAPT
Watchlist
Price: 8.62 USD 2.13% Market Closed
Market Cap: 142.5m USD
Have any thoughts about
Rapt Therapeutics Inc?
Write Note

Intrinsic Value

RAPT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one RAPT stock under the Base Case scenario is 5.92 USD. Compared to the current market price of 8.62 USD, Rapt Therapeutics Inc is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RAPT Intrinsic Value
5.92 USD
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare RAPT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RAPT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rapt Therapeutics Inc

Provide an overview of the primary business activities
of Rapt Therapeutics Inc.

What unique competitive advantages
does Rapt Therapeutics Inc hold over its rivals?

What risks and challenges
does Rapt Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Rapt Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Rapt Therapeutics Inc.

Provide P/S
for Rapt Therapeutics Inc.

Provide P/E
for Rapt Therapeutics Inc.

Provide P/OCF
for Rapt Therapeutics Inc.

Provide P/FCFE
for Rapt Therapeutics Inc.

Provide P/B
for Rapt Therapeutics Inc.

Provide EV/S
for Rapt Therapeutics Inc.

Provide EV/GP
for Rapt Therapeutics Inc.

Provide EV/EBITDA
for Rapt Therapeutics Inc.

Provide EV/EBIT
for Rapt Therapeutics Inc.

Provide EV/OCF
for Rapt Therapeutics Inc.

Provide EV/FCFF
for Rapt Therapeutics Inc.

Provide EV/IC
for Rapt Therapeutics Inc.

Show me price targets
for Rapt Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Rapt Therapeutics Inc?

How accurate were the past Revenue estimates
for Rapt Therapeutics Inc?

What are the Net Income projections
for Rapt Therapeutics Inc?

How accurate were the past Net Income estimates
for Rapt Therapeutics Inc?

What are the EPS projections
for Rapt Therapeutics Inc?

How accurate were the past EPS estimates
for Rapt Therapeutics Inc?

What are the EBIT projections
for Rapt Therapeutics Inc?

How accurate were the past EBIT estimates
for Rapt Therapeutics Inc?

Compare the revenue forecasts
for Rapt Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Rapt Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Rapt Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Rapt Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Rapt Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Rapt Therapeutics Inc with its peers.

Analyze the financial leverage
of Rapt Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Rapt Therapeutics Inc.

Provide ROE
for Rapt Therapeutics Inc.

Provide ROA
for Rapt Therapeutics Inc.

Provide ROIC
for Rapt Therapeutics Inc.

Provide ROCE
for Rapt Therapeutics Inc.

Provide Gross Margin
for Rapt Therapeutics Inc.

Provide Operating Margin
for Rapt Therapeutics Inc.

Provide Net Margin
for Rapt Therapeutics Inc.

Provide FCF Margin
for Rapt Therapeutics Inc.

Show all solvency ratios
for Rapt Therapeutics Inc.

Provide D/E Ratio
for Rapt Therapeutics Inc.

Provide D/A Ratio
for Rapt Therapeutics Inc.

Provide Interest Coverage Ratio
for Rapt Therapeutics Inc.

Provide Altman Z-Score Ratio
for Rapt Therapeutics Inc.

Provide Quick Ratio
for Rapt Therapeutics Inc.

Provide Current Ratio
for Rapt Therapeutics Inc.

Provide Cash Ratio
for Rapt Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Rapt Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Rapt Therapeutics Inc?

What is the current Free Cash Flow
of Rapt Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Rapt Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rapt Therapeutics Inc

Current Assets 183m
Other Current Assets 183m
Non-Current Assets 5m
PP&E 4m
Other Non-Current Assets 1m
Current Liabilities 8.7m
Accounts Payable 1.3m
Accrued Liabilities 7.2m
Other Current Liabilities 140k
Non-Current Liabilities 1.3m
Other Non-Current Liabilities 1.3m
Efficiency

Free Cash Flow Analysis
Rapt Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rapt Therapeutics Inc

Revenue
0 USD
Operating Expenses
-122m USD
Operating Income
-122m USD
Other Expenses
6m USD
Net Income
-116m USD
Fundamental Scores

RAPT Profitability Score
Profitability Due Diligence

Rapt Therapeutics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
24/100
Profitability
Score

Rapt Therapeutics Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

RAPT Solvency Score
Solvency Due Diligence

Rapt Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
High Altman Z-Score
76/100
Solvency
Score

Rapt Therapeutics Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RAPT Price Targets Summary
Rapt Therapeutics Inc

Wall Street analysts forecast RAPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAPT is 30.6 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Lowest
Price Target
8.08 USD
6% Downside
Average
Price Target
30.6 USD
255% Upside
Highest
Price Target
50.4 USD
485% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rapt Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RAPT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RAPT Insider Trading
Buy and sell transactions by insiders

RAPT News

What is the Intrinsic Value of one RAPT stock?

The intrinsic value of one RAPT stock under the Base Case scenario is 5.92 USD.

Is RAPT stock undervalued or overvalued?

Compared to the current market price of 8.62 USD, Rapt Therapeutics Inc is Overvalued by 31%.

Back to Top